Merck’s Singulair Probed for Potential Suicide Risk

As reports of suicidal thoughts, mood swings, and actual suicides became associated with Merck’s popular allergy and asthma drug Singulair, the FDA has decided to investigate if there is a causal relationship between the drug and suicide. Merck has updated the drug’s labeling four times in the past year to include information on a range of reported side effects: tremors, anxiousness, depression and suicidal behavior. The FDA has requested more data from Merck so that it may investigate the possibility of a causal relationship between the drug and suicide. The FDA began the probe after it received 3 or 4 suicide reports since last October.
Another popular drug, Chantix has been linked to mood disorders, suicidal thoughts, and suicides as well. Chantix is used by those who wish to quit smoking but has been found to have dangerous psychological side effects on those taking the drug and trying to quit smoking.